Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Bortezomib MeSH Descriptor Data 2025


MeSH Heading
Bortezomib
Tree Number(s)
D01.029.260.110.500
D01.132.285.500
D02.203.200.500
D03.383.679.450
Unique ID
D000069286
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000069286
Scope Note
A pyrazine and boronic acid derivative that functions as a reversible PROTEASOME INHIBITOR. It is used as an ANTINEOPLASTIC AGENT in the treatment of MULTIPLE MYELOMA and MANTLE CELL LYMPHOMA.
Entry Term(s)
LDP-341
PS 341
PS-341
Velcade
Pharm Action
Antineoplastic Agents
Registry Numbers
69G8BD63PP
0
Related Numbers
179324-69-7
Public MeSH Note
2016; BORTEZOMIB was indexed under BORONIC ACIDS and PYRAZINES 2000-2015
History Note
2016 (2000)
Date Established
2016/01/01
Date of Entry
2015/07/01
Revision Date
2016/05/27
Bortezomib Preferred
PS 341 Narrower
Velcade Narrower
LDP-341 Narrower
page delivered in 0.143s